IperionX: Titan Definitive Feasibility Study (DFS) Presentation

GlobeNewswire
06/10

Building a U.S. supply chain for heavy rare earths, titanium, zirconium and hafnium, delivering a U.S. critical mineral-to-metals platform for defense, aerospace, nuclear, semiconductors, robotics and advanced manufacturing supply chains

SOUTH BOSTON, Va., June 10, 2026 (GLOBE NEWSWIRE) --  IperionX Limited (IperionX) (NASDAQ: IPX, ASX: IPX) is pleased to provide a link to the Titan Critical Mineral Project Definitive Feasibility Study (DFS) presentation.

Link: DFS Presentation


Figure 1: IperionX DFS presentation

About IperionX

IperionX is a leading American titanium metal and critical materials company – using patented metal technologies to produce high performance titanium alloys, from titanium minerals or scrap titanium, at lower energy, cost and carbon emissions.

Our Titan critical minerals project is the largest JORC-compliant mineral resource of titanium, rare earth and zircon minerals sands in the United States.

IperionX’s titanium metal and critical minerals are essential for advanced U.S. industries including space, aerospace, defense, consumer electronics, automotive and additive manufacturing.

Contacts

Anastasios (Taso) Arima, Founder and CEO
Toby Symonds, President
Dominic Allen, Chief Commercial Officer

Investors: investorrelations@iperionx.com
Media: media@iperionx.com

+1 980 237 8900
www.iperionx.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/a99d8ffe-78fd-4dfa-8cfa-aff10fa16c28

A PDF accompanying this announcement is available at http://ml.globenewswire.com/Resource/Download/2f946720-8ad3-4d4a-a39a-71fa474242ed


免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10